Michigan Weight Navigation Program (MiWeigh) Study
The Michigan Weight Navigation Program (MiWeigh) Study
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years to 75 Years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests whether MiWeigh helps people lose more weight than getting information about weight-loss options. It is for people with a BMI of 30 or higher who have at least one weight-related health condition and want to lose weight.
The main purpose of this study is to determine whether people who participate in MiWeigh lose more weight than people who receive information about weight loss strategies and programs. The researchers also want to learn what parts of the program do and do not work and why. If the program is effective, the researchers want to learn how other health care systems could offer this program. The overarching aim of the MiWeigh Study is to better help patients prevent, manage, or reverse obesity-related chronic conditions.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Have a body mass index (BMI) of 30 or higher. BMI is a number based on height and weight.
- Have at least one of these conditions: type 2 diabetes; prediabetes (blood sugar above normal); high blood fats; high blood pressure; PCOS (a hormone condition); sleep apnea (breathing stops and starts during sleep); or MASLD (fat buildup in the liver linked to problems with how the body uses energy).
- Speak English.
- Want to lose weight.
- Be willing to complete the study's tests and check-ins.
- Be willing and able to answer messages through the online patient portal.
- Be willing to report your weight each week by text if assigned to the MiWeigh group.
- Be able to meet with a provider online at set days and times, up to four times in one year.
Who can't join
- Lost 5% or more of your weight in the past year, or had a Weight Navigation Program visit before.
- Are pregnant, planning a pregnancy, or breastfeeding in the next year.
- Are in another weight-loss program, take weight-loss medicine, or are in a study testing a diet, program, or drug to improve exercise or eating, reduce weight, or lower blood pressure or blood sugar.
- Have ever had type 1 diabetes, or have dementia (problems with memory and thinking), a serious mental health condition that is not controlled, or stage 4 or worse kidney disease.
- Have alcohol and opioid dependence, or a history of anorexia or bulimia (eating disorders).
- Had weight-loss surgery or a stomach balloon placed in the past year.
- Had intensive cancer treatment in the past six months or expect it in the next year. This includes a bone marrow transplant, chemotherapy, radiation, or cancer surgery, but not hormone treatments such as tamoxifen.
- Do not plan to live locally for the next year, or have other serious health or personal concerns that could keep you from finishing the study.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * Body Mass index (BMI) 30 kilogram per square meter or higher * Diagnosed with one or more of the following weight-related conditions: * Type 2 Diabetes * Prediabetes Mellitus * Hyperlipidemia (HLP) * Hypertension (HTN) * Polycystic Ovary Syndrome (PCOS) * Obstructive Sleep Apnea (OSA) and/or * Metabolic dysfunction-associated steatotic liver disease (MASLD) * Speaks English * Interest in losing weight * Willingness to complete assessments per study protocol * Willing and able to use the Electronic health records patient portal to respond to messages * Willing to report weight weekly by text if randomized to intervention arm * Able to see provider virtually at certain days/times up to four times in a year Exclusion Criteria: * ≥ 5% weight loss within the prior 12 months * Has had a Weight Navigation Program visit in past * Pregnant, planning a pregnancy, or breastfeeding in the next year * Ongoing participation in another weight-loss program * Taking an anti-obesity medication * Ever diagnosed with Type 1 Diabetes Mellitus (per protocol) * Dementia * Serious uncontrolled mental health conditions as indicated (per protocol) * Chronic kidney disease, Stage 4 or higher * Alcohol dependence and opioid dependence (per protocol) * History of anorexia or bulimia * Bariatric/ gastric bypass surgery, gastric sleeve surgery, or gastric balloon procedure in last year * Currently enrolled in an interventional research study that is examining how a diet, program, or drug might: promote physical exercise, healthy eating habits, or weight loss; lower blood pressure; or lower blood sugar * Not planning to live in local area over the next year * Intensive cancer treatment such as bone marrow transplant, chemotherapy, radiation, or cancer related surgery (not including hormonal chemotherapy like Tamoxifen) in last six months or next 12 months * Other serious health issues or personal concerns that could prevent participant from completing study
Study sites (1)
MI
- University of Michigan · Ann Arbor, MI 48109Shelley Stoll, MPH · Study contact · 734-232-0697 · scstoll@med.umich.eduDina Griauzde, MD, MSc · Principal investigatorMore trials in Ann Arbor